Use Able AI chat for product recommendations

Recombinant Human EPHB6 protein (rFc Tag)

Species

Human

Purity

>90 %, SDS-PAGE

Tag

rFc Tag

Activity

not tested

Cat no : Eg4219



Product Information

Purity >90 %, SDS-PAGE
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Human EPHB6 protein Leu32-Ser594 (Accession# O15197-1) with a rabbit IgG Fc tag at the C-terminus.
GeneID 2051
Accession O15197-1
PredictedSize 86.4 kDa
SDS-PAGE 85-100 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

EPHB6 (Eph receptor B6) belongs to the Eph receptor family and is a receptor tyrosine pseudokinase that lacks intrinsic kinase activity and regulates cell adhesion and migration by binding to ephrin-B family proteins. EphB6 is a protein expressed in all tissues, and has been shown to be important for the maintenance of physiological homeostasis in areas such as the kidneys, vascular smooth muscle, and immune system T cells. EphB6 is a protein expressed in all tissues and has been shown to be important for the maintenance of physiological homeostasis in areas such as the kidney, vascular smooth muscle and T cells of the immune system. (PMID: 34360976) The role of EphB6 in cancer is quite complex as it not only down-regulates and inhibits the invasiveness of a wide range of malignant tumors and cancer cells, but also supports tumorigenesis in colorectal and breast cancers. It is now suggested that the interaction of EphB6 and hepcidin B1 may control tumorigenesis, e.g., the co-aggregation of EphB6 and ephrinB1 reduced the invasiveness of the breast cancer cell line MDA-MB-231.

References:

1. Strozen TG, et al. Int J Mol Sci. 2021;22(15):8211. 2. Liang LY, et al. Commun Biol. 2024;7(1):461.

||
New chat

Able™

正在加载,请稍候...